𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children’s Oncology Group

✍ Scribed by K. Warren; R. Jakacki; B. Widemann; A. Aikin; M. Libucha; R. Packer; G. Vezina; G. Reaman; D. Shaw; M. Krailo; C. Osborne; J. Cehelsky; D. Caldwell; J. Stanwood; S. M. Steinberg; F. M. Balis

Publisher
Springer
Year
2006
Tongue
English
Weight
205 KB
Volume
58
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II investigation of docetaxel in p
Phase II investigation of docetaxel in pediatric patients with recurrent solid tumors : A report from the Children's Oncology Group
✍ Ted Zwerdling; Mark Krailo; Philip Monteleone; Rebecca Byrd; Judith Sato; Rose D 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## BACKGROUND Docetaxel, which is an antitubulin agent, has demonstrable activity against murine and human tumors. The current study was designed to determine response rates to docetaxel in various strata of recurrent solid tumors of childhood and to assess toxicity in a group of patie

Phase II study of ifosfamide in childhoo
Phase II study of ifosfamide in childhood brain tumors: A report by the French society of pediatric oncology (SFOP)
✍ Chastagner, Pascal ;Sommelet-Olive, Danièle ;Kalifa, Chantal ;Brunat-Mentigny, M 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB

## Abstract Forty‐two evaluable pediatric patients with a variety of recurrent primary brain tumors participated in a phase II ifosfamide trial. Their mean age was 10 years. All patients were treated with ifosfamide, 3 g/m^2^/day for 2 days every 2 weeks. Response was assessed on clinical and radio